iRobot (NASDAQ:IRBT) has experienced major upward momentum over the past few quarters. Surprisingly, the company is now more valuable than it was prior to the pandemic. While the coronavirus will certainly have a negative impact on iRobot in the near term, the company could end up in a stronger position compared to competitors.

iRobot recently released strong Q2 results despite the disruptions caused by COVID-19. The company reported a revenue of $279.88 million and a GAAP EPS of $2.07, beating expectations by $14.35 million and $0.80 respectively. Perhaps most promising for the company is the shift towards premium robots in its product mix. Although iRobot still has to deal with the negative impacts of the coronavirus, the company is moving in the right direction.

READ FULL ARTICLE HERE